Medtronic Australasia says it "was proud" to be recognised as one of Australia and New Zealand’s most innovative companies – ranking second in the health industry category.
The annual list, published by The Australian Financial Review and Boss Magazine, is based on an assessment process managed by a leading innovation consultancy, Inventium, in conjunction with a panel of industry expert judges.
Medtronic was ranked second on the Health Industry innovation list from over 600 nominated organisations across Australia and New Zealand.
The assessment measures a top innovation implemented in the past two years. Specifically, the judges look at how valuable the problem is that the innovation is solving, the quality and uniqueness of the solution, and the level of impact that the innovation has had. Inventium also assesses internal elements such as innovation culture, strategy, resources and process, which demonstrate a sustainable and repeatable approach to innovation. The full list can be viewed here.
Medtronic was recognised for its robotic process automation (RPA) solution for Medtronic CareLink 360 – a patient remote monitoring service.
Remote monitoring of patients with implantable pacemakers, defibrillators and cardiac monitors has improved patient survival as it allows round-the-clock surveillance of the device. However, the trade-off can result in clinicians having to manually filter and manage a deluge of data.
The RPA solution allows data from each individual device to be automatically transferred into reports. The robotic process then extracts the clinically relevant text and image data to create a summary for the patients’ healthcare provider.
Medtronic said its CareLink 360 service with RPA solution can now support more than 26,000 patients and ease manual labour for 315 cardiologists and cardiac electrophysiologists.
“At Medtronic, we continuously work with clinicians to identify ways to better support them and their patients. Once we learned that previous manual processes had been exhausted, robotic process automation was identified as the solution to take our efficiency and quality of care to a new level, which had been previously unobtainable,” said Liz Carnabuci, vice president and managing director of Medtronic Australasia.
“After being recognised for our insulin pump system last year, I’m proud to see Medtronic rise to the top of the innovative health industry once again. A true testament to the dedication of our employees in delivering state-of-the-art technology and innovation.”